Brennan Kevin M. 4
4 · Xilio Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Exercise/Conversion
Common Stock
2025-01-01+5,000→ 5,000 total - Exercise/Conversion
Restricted Stock Units
2025-01-01−5,000→ 15,000 total→ Common Stock (5,000 underlying) - Sale
Common stock
2025-01-02$0.98/sh−1,803$1,774→ 3,197 total - Award
Stock Option (right to buy)
2025-01-01+60,000→ 60,000 totalExercise: $0.95Exp: 2035-12-31→ Common Stock (60,000 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs) convert to stock on a one-for-one basis
- [F2]The reported sale of 1,803 shares occurred automatically in a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2024 solely to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
- [F4]The option was granted on January 1, 2025 and will vest in 48 equal monthly installments beginning on February 1, 2025 and continuing through January 1, 2029.